MedPath

KLSMC Stem Cells, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
1 (100.0%)

Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee

Phase 2
Completed
Conditions
Articular Cartilage Disorder of Knee
Articular Cartilage; Degeneration
First Posted Date
2017-04-04
Last Posted Date
2022-08-16
Lead Sponsor
KLSMC Stem Cells, Inc.
Target Recruit Count
120
Registration Number
NCT03101163
Locations
πŸ‡ΊπŸ‡Έ

Andrews Research & Education Foundation (AREF), Gulf Breeze, Florida, United States

πŸ‡²πŸ‡Ύ

Kuala Lumpur Sports Medicine Centre, Kuala Lumpur, Malaysia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.